161Tb-Based Anti-L1CAM Radioimmunotherapy Shows Superior Efficacy in Eliminating Ovarian Cancer Stem Cells Compared with 177Lu in Preclinical Models of Ovarian Cancer.
Saved in:
| Title: | 161Tb-Based Anti-L1CAM Radioimmunotherapy Shows Superior Efficacy in Eliminating Ovarian Cancer Stem Cells Compared with 177Lu in Preclinical Models of Ovarian Cancer. |
|---|---|
| Authors: | Todorov, Tihomir Zh.1,2,3 (AUTHOR), Coelho, Ricardo2 (AUTHOR), Dellea, Sharon1 (AUTHOR), Jacob, Francis2 (AUTHOR), Heinzelmann-Schwarz, Viola2,4 (AUTHOR), Grundler, Pascal V.1 (AUTHOR), van der Meulen, Nicholas P.1,5 (AUTHOR), Béhé, Martin P.1 (AUTHOR), Schibli, Roger1,3 (AUTHOR) juergen.gruenberg@psi.ch, Grünberg, Jürgen1 (AUTHOR) roger.schibli@psi.ch |
| Source: | Journal of Nuclear Medicine. Jul2025, Vol. 66 Issue 7, p1091-1096. 6p. |
| Database: | Engineering Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 01615505 |
|---|---|
| DOI: | 10.2967/jnumed.124.269078 |
